Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Alzheimer's Disease

  Free Subscription


Articles published in BMJ

Retrieve available abstracts of 24 articles:
HTML format
Text format



Single Articles


    February 2017
  1. HAWKES N
    Merck ends trial of potential Alzheimer's drug verubecestat.
    BMJ. 2017;356:j845.
    PubMed     Text format    


    December 2016
  2. LE COUTEUR DG, Hunter S, Brayne C
    Solanezumab and the amyloid hypothesis for Alzheimer's disease.
    BMJ. 2016;355:i6771.
    PubMed     Text format    


  3. MAYOR S
    Statins are linked to reduced Alzheimer's risk, study finds.
    BMJ. 2016;355:i6675.
    PubMed     Text format    


    November 2016
  4. HAWKES N
    Promise of new Alzheimer's drug is dashed after lack of evidence.
    BMJ. 2016;355:i6362.
    PubMed     Text format    


    January 2016
  5. HAWKES N
    Amyloid plaques are still main target for Alzheimer's drugs.
    BMJ. 2016;352:i214.
    PubMed     Text format    


  6. WISE J
    Higher levels of mercury in brain are not linked to increased risk of Alzheimer's, study finds.
    BMJ. 2016;352:i611.
    PubMed     Text format    


  7. GRAY SL, Dublin S, Yu O, Walker R, et al
    Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study.
    BMJ. 2016;352:i90.
    PubMed     Text format     Abstract available


  8. WISE J
    No "breakthrough" in Alzheimer's disease.
    BMJ. 2016;354:i4474.
    PubMed     Text format    


  9. WISE J
    Dementia and flu are blamed for increase in deaths in 2015 in England and Wales.
    BMJ. 2016;353:i2022.
    PubMed     Text format    


  10. HOPKINS TANNE J
    Approved drugs are to be studied for use in Alzheimer's disease.
    BMJ. 2016;354:i5063.
    PubMed     Text format    


    January 2015
  11. MAYOR S
    Signs of depression and apathy precede memory problems in Alzheimer's disease, study shows.
    BMJ. 2015;350:h190.
    PubMed     Text format    


  12. HAWKES N
    Hopes rise for new Alzheimer's drug after secondary analysis.
    BMJ. 2015;351:h4048.
    PubMed     Text format    


  13. MCCARTNEY M
    Margaret McCartney: The "breakthrough" drug that's not been shown to help in Alzheimer's disease.
    BMJ. 2015;351:h4064.
    PubMed     Text format    


  14. TORGERSON D
    Need for a trial of solanezumab in mild Alzheimer's disease.
    BMJ. 2015;351:h4441.
    PubMed     Text format    


  15. MAYOR S
    Peptides that form amyloid plaques in Alzheimer's may be transmissible, study finds.
    BMJ. 2015;351:h4831.
    PubMed     Text format    


  16. WISE J
    Combination drug shows promise for treating agitation in patients with Alzheimer's disease.
    BMJ. 2015;351:h5015.
    PubMed     Text format    


  17. COHEN JP, Dong J, Lu CY, Chakravarthy R, et al
    Restricting access to florbetapir: Medicare coverage criteria for diagnostics and drugs are inconsistent.
    BMJ. 2015;351:h3333.
    PubMed     Text format    


  18. TORJESEN I
    Continuing donepezil when Alzheimer symptoms worsen might delay nursing home admission, study indicates.
    BMJ. 2015;351:h5739.
    PubMed     Text format    


  19. MCCARTNEY M
    Author's reply to Karran.
    BMJ. 2015;351:h4532.
    PubMed     Text format    


  20. KARRAN E
    Recent trial shows that solanezumab has disease modifying effects.
    BMJ. 2015;351:h4528.
    PubMed     Text format    


  21. MAYOR S
    Slow walking speed may be early sign of Alzheimer's in older people, study finds.
    BMJ. 2015;351:h6506.
    PubMed     Text format    


  22. ZUCKERMAN DM, Jury NJ, Silcox CE
    21st Century Cures Act and similar policy efforts: at what cost?
    BMJ. 2015;351:h6122.
    PubMed     Text format    


    January 2014
  23. HUGHES J
    Alzheimer's Society's response to Dementiagate.
    BMJ. 2014;349:g6838.
    PubMed     Text format    


  24. MCCARTHY M
    Study supports link between low vitamin D and dementia risk.
    BMJ. 2014;349:g5049.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: